Tekla Healthcare Investors Stock Forecast, Price & News

Wall Street analysts have given Tekla Healthcare Investors a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tekla Healthcare Investors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Tekla Healthcare Investors saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 161,300 shares, an increase of 165.7% from the August 15th total of 60,700 shares. Based on an average daily volume of 120,700 shares, the short-interest ratio is currently 1.3 days.
View Tekla Healthcare Investors' Short Interest.

Tekla Healthcare Investors' stock was trading at $17.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HQH stock has increased by 49.7% and is now trading at $26.75.
View which stocks have been most impacted by COVID-19.

Tekla Healthcare Investors declared a quarterly dividend on Wednesday, August 18th. Stockholders of record on Friday, August 27th will be given a dividend of $0.52 per share on Thursday, September 30th. This represents a $2.08 dividend on an annualized basis and a yield of 7.78%. The ex-dividend date is Thursday, August 26th. This is a positive change from Tekla Healthcare Investors's previous quarterly dividend of $0.50.
View Tekla Healthcare Investors' dividend history.

Tekla Healthcare Investors pays an annual dividend of $2.01 per share and currently has a dividend yield of 7.57%. HQH has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Tekla Healthcare Investors' dividend history.

Some companies that are related to Tekla Healthcare Investors include SPDR Nuveen Barclays Municipal Bond ETF (TFI), DNP Select Income Fund (DNP), Direxion Daily Financial Bull 3X Shares (FAS), iShares MSCI Pacific ex Japan ETF (EPP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate & Income Opportunity Fund (PTY), WisdomTree Emerging Markets High Dividend Fund (DEM), Hercules Capital (HTGC), Goldman Sachs BDC (GSBD), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Tri-Continental (TY), The Gabelli Equity Trust (GAB) and iShares MSCI Australia ETF (EWA).
View all of HQH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Main Street Capital (MAIN), Energy Transfer (ET), PIMCO Dynamic Credit and Mortgage Income Fund (PCI), Ares Capital (ARCC), Annaly Capital Management (NLY), Gilead Sciences (GILD), Iron Mountain (IRM) and AbbVie (ABBV).

Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."

Tekla Healthcare Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (6.89%), Morgan Stanley (6.89%), Royal Bank of Canada (1.24%), Wells Fargo & Company MN (0.89%), Lazard Asset Management LLC (0.75%) and LPL Financial LLC (0.66%).
View institutional ownership trends for Tekla Healthcare Investors.

HQH stock was sold by a variety of institutional investors in the last quarter, including Punch & Associates Investment Management Inc., 1832 Asset Management L.P., 1832 Asset Management L.P., Lazard Asset Management LLC, City of London Investment Management Co. Ltd., Matisse Capital, Bank of America Corp DE, and Claraphi Advisory Network LLC.
View insider buying and selling activity for Tekla Healthcare Investors or view top insider-selling stocks.

HQH stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Royal Bank of Canada, Private Advisor Group LLC, LPL Financial LLC, B. Riley Wealth Management Inc., First Trust Advisors LP, and Advisor Group Holdings Inc..
View insider buying and selling activity for Tekla Healthcare Investors or or view top insider-buying stocks.

Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HQH stock can currently be purchased for approximately $26.75.

Tekla Healthcare Investors has a market capitalization of $1.19 billion.

Tekla Healthcare Investors employs 147,000 workers across the globe.

The official website for Tekla Healthcare Investors is www.teklacap.com.

Tekla Healthcare Investors is headquartered at 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109.

Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at (617) 772-8500 or via email at [email protected]